530091 — Zyden Gentec Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Zyden Gentec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2011 March 31st | 2012 March 31st | C2013 March 31st | R2014 March 31st | 2015 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IAS | IAS | IAS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 121 | 95.1 | 141 | 15.9 | 3.38 |
Cost of Revenue | |||||
Gross Profit | 25.2 | -14.8 | 2.92 | -4.68 | 0.225 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 113 | 129 | 152 | 31.5 | 6.7 |
Operating Profit | 7.77 | -33.4 | -11.6 | -15.6 | -3.31 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.247 | -44.6 | -6.22 | -2.65 | 3.61 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.08 | -41 | -6.22 | -2.65 | 3.61 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.08 | -41 | -6.22 | -2.65 | 3.61 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.08 | -41 | -6.22 | -2.65 | 3.61 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.043 | -0.737 | -0.112 | -0.048 | 0.065 |
Dividends per Share |